Rheinmetall's Danish Decoy Deal Caps a Week of Whiplash as Wall Street and Frankfurt Split on the Stock

Rheinmetall shares climb 2.7% after Jefferies raises target, but remain 40% below peak amid mixed analyst views and record backlog.

The Düsseldorf-based defence group has spent the past seven days delivering a masterclass in mixed messaging. On Thursday, management hailed what it called the best quarter in the company's 137-year history and raised its full-year guidance. By Friday afternoon, the shares had clawed back to €1,207.00 — up 2.7 per cent on the session — yet the stock still trades roughly 40 per cent below its 52-week peak of €2,007.00.

The immediate catalyst for Friday's bounce was a fresh vote of confidence from Jefferies, which lifted its price target on Rheinmetall to €1,350 from €1,300 while reaffirming a "Buy" rating. That call arrived hot on the heels of Royal Bank of Canada's initiation of coverage on 11 August with an "Outperform" recommendation and a far more ambitious €1,600 target. Both houses point to the same rationale: an operating performance that prompted management to lift its outlook for the full year.

Yet the bull case is not going unanswered. Just three days before RBC's initiation, mwb research had moved in the opposite direction, downgrading the stock from "Hold" to "Sell" on 8 August and slashing its price objective to €1,050 from €1,150. The German research house cited a deteriorating risk-reward profile, criticism of the company's halved investment ratio of 8 to 9 per cent, and a lowered backlog target.

That divergence captures the broader investor uncertainty that has surrounded the stock since the half-year numbers landed. The market's initial reaction was brutal — the shares fell as much as 8.5 per cent on the day of the report — before the recovery that has now extended over seven sessions, accumulating a 5.4 per cent gain in the process. Friday's close leaves the equity about 10 per cent above its 50-day moving average of €1,096.84, suggesting the rebound carries more weight than a purely technical snap-back.

A Scandinavian Signal in the Naval Segment

Adding to the momentum was confirmation on Friday of a new contract with the Danish armed forces. Rheinmetall will supply its MASS (Multi Ammunition Softkill System) naval decoy launchers and Omnitrap-ER countermeasure dispensers for frigates of the Absalon and Iver Huitfeldt classes. The order, valued in the low double-digit millions of euros, is scheduled for delivery from the fourth quarter of 2027.

The deal extends a run of Scandinavian naval wins that have accumulated over recent weeks, including the modernisation of the frigate Bayern roughly a fortnight ago. While the Danish order is modest in size relative to the group's land-systems and ammunition mega-programmes, it reinforces Rheinmetall's positioning as a preferred supplier to Nordic navies upgrading their fleets with modern self-protection systems. The company has not disclosed specific contract values, but the strategic signal matters more than the ticket size.

The Backlog Machine Keeps Turning

The order book tells the growth story more forcefully. As of 30 June, Rheinmetall's backlog stood at €80.467 billion, a substantial jump from €55.972 billion a year earlier. That expansion is the foundation on which the company's long-term narrative rests — and the reason why the analyst community remains so sharply divided on valuation.

The counterweight is cash. Operating free cash flow came in at minus €1.660 billion for the first half, compared with minus €0.644 billion in the prior-year period. Capital intensity is rising as the group pours money into expanding production capacity, particularly in the United States, where subsidiary American Rheinmetall completed the acquisition of vehicle specialist Loc Performance in late November 2024 — a move designed to cement the group's foothold in the American defence market.

Two Dates on the Calendar

Investors now have two markers to watch. On 26 August, Rheinmetall participates in the DZ Bank Expert Day in Bremen; on 19 October, management is scheduled to deliver a strategy update. Both events could shed further light on the medium-term growth trajectory and reignite the debate over a valuation that, despite the recent recovery, remains well below its historical highs.